Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions

Chia Chun Hung, El Wui Loh, Tsung Ming Hu, Hsien Jane Chiu, Hung Chieh Hsieh, Chin Hong Chan, Tsuo Hung Lan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Preventing and managing hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is an important public health issue worldwide, and Taiwan is one of the countries where viral hepatitis is most endemic. Previous studies have shown that patients with serious mental illnesses have a higher risk for hepatitis infection. We investigated the prevalence of HBV and HCV among institutionalized patients with chronic schizophrenia in Taiwan. Methods: A total of 590 patients were recruited into the study. HBV surface antigen, HCV antibody, and liver function were determined for all participants. Results: The seroprevalence of HBV surface antigen was 10.4% (males 12.6%, females 7.0%), and that of anti-HCV was 1.9% (males 2.6%, females 0.8%). Conclusion: Our study showed that the prevalences of HBV and HCV among institutionalized patients with chronic schizophrenia were no higher than the prevalences in the general population in Taiwan. The commodious environment and medical resources of the hospital where the patients were living might have prevented an elevation of HBV and HCV infection in those with schizophrenia, supplementing the continuing benefits from the HBV vaccination that was introduced in 1984.

Original languageEnglish
Pages (from-to)275-280
Number of pages6
JournalJournal of the Chinese Medical Association
Volume75
Issue number6
DOIs
Publication statusPublished - Jun 1 2012
Externally publishedYes

Fingerprint

Hepatitis C
Hepatitis B
Hepatitis B virus
Schizophrenia
Hepacivirus
Taiwan
Virus Diseases
Hepatitis B Surface Antigens
Hepatitis
Hepatitis C Antibodies
Seroepidemiologic Studies
Vaccination
Public Health
Cross-Sectional Studies
Liver
Infection
Population

Keywords

  • Hepatitis B
  • Hepatitis C
  • Prevalence
  • Schizophrenia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions. / Hung, Chia Chun; Loh, El Wui; Hu, Tsung Ming; Chiu, Hsien Jane; Hsieh, Hung Chieh; Chan, Chin Hong; Lan, Tsuo Hung.

In: Journal of the Chinese Medical Association, Vol. 75, No. 6, 01.06.2012, p. 275-280.

Research output: Contribution to journalArticle

Hung, Chia Chun ; Loh, El Wui ; Hu, Tsung Ming ; Chiu, Hsien Jane ; Hsieh, Hung Chieh ; Chan, Chin Hong ; Lan, Tsuo Hung. / Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions. In: Journal of the Chinese Medical Association. 2012 ; Vol. 75, No. 6. pp. 275-280.
@article{6086a584954749f2ad9eaea6ab698867,
title = "Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions",
abstract = "Background: Preventing and managing hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is an important public health issue worldwide, and Taiwan is one of the countries where viral hepatitis is most endemic. Previous studies have shown that patients with serious mental illnesses have a higher risk for hepatitis infection. We investigated the prevalence of HBV and HCV among institutionalized patients with chronic schizophrenia in Taiwan. Methods: A total of 590 patients were recruited into the study. HBV surface antigen, HCV antibody, and liver function were determined for all participants. Results: The seroprevalence of HBV surface antigen was 10.4{\%} (males 12.6{\%}, females 7.0{\%}), and that of anti-HCV was 1.9{\%} (males 2.6{\%}, females 0.8{\%}). Conclusion: Our study showed that the prevalences of HBV and HCV among institutionalized patients with chronic schizophrenia were no higher than the prevalences in the general population in Taiwan. The commodious environment and medical resources of the hospital where the patients were living might have prevented an elevation of HBV and HCV infection in those with schizophrenia, supplementing the continuing benefits from the HBV vaccination that was introduced in 1984.",
keywords = "Hepatitis B, Hepatitis C, Prevalence, Schizophrenia",
author = "Hung, {Chia Chun} and Loh, {El Wui} and Hu, {Tsung Ming} and Chiu, {Hsien Jane} and Hsieh, {Hung Chieh} and Chan, {Chin Hong} and Lan, {Tsuo Hung}",
year = "2012",
month = "6",
day = "1",
doi = "10.1016/j.jcma.2012.03.002",
language = "English",
volume = "75",
pages = "275--280",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "6",

}

TY - JOUR

T1 - Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions

AU - Hung, Chia Chun

AU - Loh, El Wui

AU - Hu, Tsung Ming

AU - Chiu, Hsien Jane

AU - Hsieh, Hung Chieh

AU - Chan, Chin Hong

AU - Lan, Tsuo Hung

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Background: Preventing and managing hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is an important public health issue worldwide, and Taiwan is one of the countries where viral hepatitis is most endemic. Previous studies have shown that patients with serious mental illnesses have a higher risk for hepatitis infection. We investigated the prevalence of HBV and HCV among institutionalized patients with chronic schizophrenia in Taiwan. Methods: A total of 590 patients were recruited into the study. HBV surface antigen, HCV antibody, and liver function were determined for all participants. Results: The seroprevalence of HBV surface antigen was 10.4% (males 12.6%, females 7.0%), and that of anti-HCV was 1.9% (males 2.6%, females 0.8%). Conclusion: Our study showed that the prevalences of HBV and HCV among institutionalized patients with chronic schizophrenia were no higher than the prevalences in the general population in Taiwan. The commodious environment and medical resources of the hospital where the patients were living might have prevented an elevation of HBV and HCV infection in those with schizophrenia, supplementing the continuing benefits from the HBV vaccination that was introduced in 1984.

AB - Background: Preventing and managing hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is an important public health issue worldwide, and Taiwan is one of the countries where viral hepatitis is most endemic. Previous studies have shown that patients with serious mental illnesses have a higher risk for hepatitis infection. We investigated the prevalence of HBV and HCV among institutionalized patients with chronic schizophrenia in Taiwan. Methods: A total of 590 patients were recruited into the study. HBV surface antigen, HCV antibody, and liver function were determined for all participants. Results: The seroprevalence of HBV surface antigen was 10.4% (males 12.6%, females 7.0%), and that of anti-HCV was 1.9% (males 2.6%, females 0.8%). Conclusion: Our study showed that the prevalences of HBV and HCV among institutionalized patients with chronic schizophrenia were no higher than the prevalences in the general population in Taiwan. The commodious environment and medical resources of the hospital where the patients were living might have prevented an elevation of HBV and HCV infection in those with schizophrenia, supplementing the continuing benefits from the HBV vaccination that was introduced in 1984.

KW - Hepatitis B

KW - Hepatitis C

KW - Prevalence

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84862546714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862546714&partnerID=8YFLogxK

U2 - 10.1016/j.jcma.2012.03.002

DO - 10.1016/j.jcma.2012.03.002

M3 - Article

C2 - 22721622

AN - SCOPUS:84862546714

VL - 75

SP - 275

EP - 280

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 6

ER -